Idiotype-pulsed antigen presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

Vaccines are attractive as consolidation therapy after autologous stem cell transplantation (ASCT) for multiple myeloma (MM). We report the results of a phase II trial of the immunotherapeutic, APC8020 (Mylovenge™), given after ASCT for MM. We compared the results with that of other patients with MM...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lacy, Martha Q., Mandrekar, Sumithra, Dispenzieri, Angela, Hayman, Suzanne, Kumar, Shaji, Buadi, Francis, Dingli, David, Litzow, Mark, Wettstein, Peter, Padley, Douglas, Kabat, Brian, Gastineau, Dennis, Rajkumar, S. Vincent, Gertz, Morie A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2908015/
https://ncbi.nlm.nih.gov/pubmed/19899131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.21560
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky